Unknown

Dataset Information

0

HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination.


ABSTRACT: Integrase inhibitors are a class of antiretroviral drugs used for the treatment of AIDS that target HIV integrase, an enzyme responsible for integration of viral cDNA into host genome. RAG1, a critical enzyme involved in V(D)J recombination exhibits structural similarity to HIV integrase. We find that two integrase inhibitors, Raltegravir and Elvitegravir, interfered with the physiological functions of RAGs such as binding, cleavage and hairpin formation at the recombination signal sequence (RSS), though the effect of Raltegravir was limited. Circular dichroism studies demonstrated a distinct change in the secondary structure of RAG1 central domain (RAG1 shares DDE motif amino acids with integrases), and when incubated with Elvitegravir, an equilibrium dissociation constant (Kd) of 32.53±2.9??M was determined by Biolayer interferometry, leading to inhibition of its binding to DNA. Besides, using extrachromosomal assays, we show that Elvitegravir inhibited both coding and signal joint formation in pre-B cells. Importantly, treatment with Elvitegravir resulted in significant reduction of mature B lymphocytes in 70% of mice studied. Thus, our study suggests a potential risk associated with the use of Elvitegravir as an antiretroviral drug, considering the evolutionary and structural similarities between HIV integrase and RAGs.

SUBMITTER: Nishana M 

PROVIDER: S-EPMC5520896 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination.

Nishana Mayilaadumveettil M   Nilavar Namrata M NM   Kumari Rupa R   Pandey Monica M   Raghavan Sathees C SC  

Cell death & disease 20170601 6


Integrase inhibitors are a class of antiretroviral drugs used for the treatment of AIDS that target HIV integrase, an enzyme responsible for integration of viral cDNA into host genome. RAG1, a critical enzyme involved in V(D)J recombination exhibits structural similarity to HIV integrase. We find that two integrase inhibitors, Raltegravir and Elvitegravir, interfered with the physiological functions of RAGs such as binding, cleavage and hairpin formation at the recombination signal sequence (RSS  ...[more]

Similar Datasets

| S-EPMC2660292 | biostudies-literature
| S-EPMC4621128 | biostudies-other
| S-EPMC3115487 | biostudies-literature
| S-EPMC7380719 | biostudies-literature